Health Canada drug identification number

DIN 02126613 — CISPLATIN INJECTION BP 1 MG

CISPLATIN INJECTION BP is a solution of Cisplatin marketed by PFIZER CANADA ULC. The full Cisplatin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02126613
Brand name
CISPLATIN INJECTION BP
Active ingredient
Cisplatin
Strength
1 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
Platinum-based alkylating antineoplastic agent

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Cisplatin products

DINBrandStrengthFormManufacturerStatus
02403188 CISPLATIN INJECTION 1.0 MG SOLUTION TEVA CANADA LIMITED MARKETED
02536285 CISPLATIN INJECTION BP 1 MG SOLUTION HIKMA CANADA LIMITED MARKETED
02355183 CISPLATIN INJECTION, BP 1 MG SOLUTION ACCORD HEALTHCARE INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.